The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study (HIPP)

September 20, 2017 updated by: Andrew Hartwick, Ohio State University
After a head injury, many people find that exposure to light causes them increased discomfort. By measuring how the pupil in the eye constricts to flashes of red and blue light, this study will investigate whether this phenomenon is due to a change in the eye's sensitivity to light.

Study Overview

Detailed Description

The pupils inside the eyes constrict in response to light stimulation. Different classes of cells within the human retina initiate this response. Recent research suggests that one of the ganglion cell types involved in this pupil response also plays a role in the photophobia experienced by migraine sufferers. The main aim of this study is to determine whether this type of ganglion cell becomes 'hypersensitive' after traumatic brain injury, thereby contributing to symptoms of increased photosensitivity experienced by many of these individuals.

In the first session of this study, subjects will be asked questions about their sensitivity to light and the reaction of their eyes' pupils to flashing red and blue lights will be measured. The subjects will be given a full eye examination to rule out other causes of increased photosensitivity.

In some cases, subjects will be asked to attend a second session roughly two weeks later. They will be asked to wear a watch that measures their daily activity/sleep rhythms and light exposure during this inter-session period. During the second session, further testing of the pupil responses to blue and red flickering light will be performed.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43210
        • College of Optometry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Cases: Age 18 or older with symptoms of increased photosensitivity since experiencing a head injury.

Controls: Matched to cases in age, sex and race.

Description

Inclusion Criteria:

  • 18+ years old
  • reports a previous head injury that occurred at least 6 months ago
  • score of 2 or 3 (mild TBI) on OSU-TBI ID Survey
  • best-corrected visual acuity of at least 20/30 in both eyes
  • reliable visual field

Exclusion Criteria:

  • pregnancy
  • significant afferent pupillary defect
  • previous history of neurodegenerative disease
  • intraocular pressure more than 21 mm Hg
  • significant visual field defect
  • active corneal pathology
  • history of retinal or optic nerve disease
  • strabismus (eye turn)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Case Subjects
  1. Age 18 years or older
  2. Had a head injury that occurred at least 6 months prior to entering study
  3. Have found lights more bothersome since injury
Control Subjects
  1. Age 18 years or older
  2. Have not had a previous head injury
  3. Have had a full eye examination at Ohio State University College of Optometry during last 6 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pupil Responses
Time Frame: 2 weeks
The pupil fluctuation evoked by blue and red flickering lights will be measured in patients with a prior brain injury and compared to matched controls.
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep Rhythms
Time Frame: 2 weeks
Daily rhythms of sleep and activity will be assessed in subjects with prior brain injury and compared to matched controls.
2 weeks
Light Exposure
Time Frame: 2 weeks
The exposure to red, blue and green components of the light spectrum will be quantified in patients with a prior brain injury, and compared to matched controls.
2 weeks
Photosensitivity Symptoms
Time Frame: Single visit - one day
Subjects will complete survey indicating symptoms they have experienced related to light sensitivity and will grade their discomfort after exposed to brief flashes of light.
Single visit - one day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrew Hartwick, OD, PhD, Ohio State University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

September 6, 2013

First Submitted That Met QC Criteria

September 13, 2013

First Posted (Estimate)

September 16, 2013

Study Record Updates

Last Update Posted (Actual)

September 25, 2017

Last Update Submitted That Met QC Criteria

September 20, 2017

Last Verified

September 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Head Injury

3
Subscribe